Detalhe da pesquisa
1.
Macrophage and neutrophil death programs differentially confer resistance to tuberculosis.
Immunity
; 54(8): 1758-1771.e7, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34256013
2.
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies.
Semin Immunol
; 65: 101672, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36469987
3.
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
N Engl J Med
; 388(10): 873-887, 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808186
4.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
N Engl J Med
; 387(25): 2331-2343, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546625
5.
Prediction Models for Adverse Drug Reactions During Tuberculosis Treatment in Brazil.
J Infect Dis
; 229(3): 813-823, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262629
6.
Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis.
Clin Infect Dis
; 78(4): 1043-1052, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962987
7.
Evidence for Tuberculosis in Individuals With Xpert Ultra "Trace" Sputum During Screening of High-Burden Communities.
Clin Infect Dis
; 78(3): 723-729, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787077
8.
Pre-extensively Drug-Resistant Congenital Tuberculosis in an Extremely Premature Baby.
Clin Infect Dis
; 78(1): 149-153, 2024 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37681559
9.
Inhibition of leukotriene-B4 signalling-mediated host response to tuberculosis is a potential mode of adjunctive host-directed therapy.
Immunology
; 172(3): 392-407, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504502
10.
Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis.
Antimicrob Agents Chemother
; 68(5): e0101023, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38501805
11.
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
N Engl J Med
; 384(18): 1705-1718, 2021 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951360
12.
Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysis.
Thorax
; 79(2): 169-178, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135489
13.
Extrapolation of lung pharmacokinetics of antitubercular drugs from preclinical species to humans using PBPK modelling.
J Antimicrob Chemother
; 79(6): 1362-1371, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598449
14.
Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistant tuberculosis in Indonesia.
J Antimicrob Chemother
; 79(5): 977-986, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459759
15.
Sex and Gender Differences in Tuberculosis Pathogenesis and Treatment Outcomes.
Curr Top Microbiol Immunol
; 441: 139-183, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37695428
16.
Time to sputum culture conversion and its associated factors among drug-resistant tuberculosis patients: a systematic review and meta-analysis.
BMC Infect Dis
; 24(1): 169, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326758
17.
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis.
BMC Infect Dis
; 24(1): 7, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166793
18.
Radiographic characteristics of rifampicin-resistant tuberculosis in the STREAM stage 1 trial and their influence on time to culture conversion in the short regimen.
BMC Infect Dis
; 24(1): 144, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291393
19.
Tuberculosis treatment delay and associated factors among pulmonary tuberculosis patients at public health facilities in Dale District and Yirgalem Town administration, Sidama Region, South Ethiopia.
BMC Infect Dis
; 24(1): 517, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38783203
20.
Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019-2021.
BMC Infect Dis
; 24(1): 511, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773443